Table of Contents
ISRN Gastroenterology
Volume 2013, Article ID 526024, 9 pages
http://dx.doi.org/10.1155/2013/526024
Review Article

Hepatocellular Carcinoma More Than 3 cm in Diameter: A Systematic Review of Transcatheter Arterial Chemoembolization Plus Percutaneous Ethanol Injection versus Transcatheter Arterial Chemoembolization Alone

1Department of Integrative Oncology, Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai 200032, China
2Department of Oncology, Shanghai Medical College, Fudan University, 130 Dong An Road, Shanghai 200032, China

Received 11 May 2013; Accepted 17 June 2013

Academic Editors: A. Amedei, A. J. Karayiannakis, and C.-T. Shun

Copyright © 2013 Shiying Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. K. Tesdal, M. Wikström, C. Flechtenmacher, T. Filser, and C. Dueber, “Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts,” CardioVascular and Interventional Radiology, vol. 29, no. 5, pp. 778–784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Tanaka, H. Okazaki, S. Nakamura et al., “Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection,” Radiology, vol. 179, no. 3, pp. 713–717, 1991. View at Google Scholar · View at Scopus
  3. F. S. Ferrari, A. Stella, D. Gambacorta et al., “Treatment of large hepatocellular carcinoma: comparison between techniques and long term results,” Radiologia Medica, vol. 108, no. 4, pp. 356–371, 2004. View at Google Scholar · View at Scopus
  4. G. Becker, T. Soezgen, M. Olschewski, J. Laubenberger, H. E. Blum, and H. Allgaier, “Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 11, no. 39, pp. 6104–6109, 2005. View at Google Scholar · View at Scopus
  5. C. Bartolozzi, R. Lencioni, D. Caramella et al., “Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization,” Radiology, vol. 197, no. 3, pp. 812–818, 1995. View at Google Scholar · View at Scopus
  6. T. Kato, Y. Saito, M. Niwa, J. Ishiguro, and K. Ogoshi, “Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma,” Cancer Chemotherapy and Pharmacology, vol. 33, supplement 1, pp. S115–S118, 1994. View at Google Scholar · View at Scopus
  7. N. Wang, Q. Guan, K. Wang et al., “TACE combined with PEI versus TACE alone in the treatment of HCC: a meta-analysis,” Medical Oncology, vol. 28, no. 4, pp. 1038–1043, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. D. Oxman, “Grading quality of evidence and strength of recommendations,” British Medical Journal, vol. 328, no. 7454, pp. 1490–1494, 2004. View at Google Scholar · View at Scopus
  9. G. H. Guyatt, A. D. Oxman, G. E. Vist et al., “GRADE: an emerging consensus on rating quality of evidence and strength of recommendations,” British Medical Journal, vol. 336, no. 7650, pp. 924–926, 2008. View at Google Scholar · View at Scopus
  10. Y. X. Deng, “The efficacy of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma,” Journal of Youjiang Medical College for Nationalities, pp. 650–652, 2004. View at Google Scholar
  11. G. Guo, Q. G. Chen, and C. W. Yang, “Efficacy of percutaneous ethanol injection combing with transcatherter arterial chemoembolization for hepatocellular carcinoma,” Journal of Hainan Medical College, vol. 18, pp. 77–79, 2012. View at Google Scholar
  12. J. Y. Huang, W. Z. Yang, N. Jiang, Q. B. Zheng, S. Yang, and N. Huang, “Treatment of primary hepatic carcinoma with transcatheter hepatic arterial chemoembolization and CT guided percutaneous ethanol injection,” China Oncology, vol. 10, pp. 71–72, 2000. View at Google Scholar
  13. K. M. Hu, Z. X. Sun, Y. Zhang, Z. C. Wang, and C. S. Wang, “Transcatheter arterial chemoembolization(TACE) combined with percutaneous ethanol injection(PEI) in the treatment of primary hepatocellular carcinoma(HCC),” China Journal of Modern Medicine, vol. 21, pp. 678–681, 2011. View at Google Scholar
  14. H. Liu, Z. S. Liu, Y. F. Yuan, Y. M. He, and Q. Qian, “Combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of unresectable hepatocellular carcinoma,” Journal of New Medicine, vol. 17, pp. 2–4, 2007. View at Google Scholar
  15. W. X. Wang, H. Z. Yue, and G. X. Zhou, “Combination of transcatheter arterial chemoembolization and CT-guided Percutaneous ethanol injection therapy in treating advanced hepatocellular carcinoma,” China Journal of Modern Medicine, vol. 15, pp. 2545–2548, 2005. View at Google Scholar
  16. W. Peihong, L. Li, and Z. Yunin, “Transcatheter arterial chemo-embolization combined with CT-guided percutaneous intratumoral injection of lipiodol-ethanol for the treatment of primary hepatocellular carcinoma,” Chinese Journal of Oncology, vol. 20, no. 5, pp. 391–393, 1998. View at Google Scholar · View at Scopus
  17. G. H. Xu, H. C. Wen, Z. W. Li et al., “Evaluation of hepatic chemoembolization and percutaneous ethanol injection in the treatment of HCC,” Chinese Journal of Radiology, vol. 21, pp. 66–68, 2002. View at Google Scholar
  18. S. B. Zan, D. F. Li, and S. L. Dong, “Transcatheter arterial chemoembolization(TACE) combined with percutaneous ethanol injection(PEI) for the treatment of primary hepatocellular carcinoma(HCC),” China Modern Doctor, vol. 46, pp. 84–85, 2008. View at Google Scholar
  19. J. P. T. Higgins and S. Green, Eds., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, The Cochrane Collaboration, Oxford, UK, 2011.
  20. M. C. Jansen, R. van Hillegersberg, R. A. F. M. Chamuleau, O. M. van Delden, D. J. Gouma, and T. M. van Gulik, “Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review,” European Journal of Surgical Oncology, vol. 31, no. 4, pp. 331–347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Kirikoshi, S. Saito, M. Yoneda et al., “Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma,” Hepatology Research, vol. 39, no. 6, pp. 553–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. K. N. Kahn, K. Nakata, Y. Kusumoto et al., “Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma,” Cancer Research, vol. 51, no. 20, pp. 5667–5671, 1991. View at Google Scholar · View at Scopus